Kidney drug shows promise for eye health in new trial
NCT ID NCT07235891
First seen Nov 19, 2025 · Last updated May 16, 2026 · Updated 19 times
Summary
This study will test if the drug finerenone can protect the retina (the light-sensitive part of the eye) in 40 adults with chronic kidney disease. Researchers will measure changes in the thickness of the retinal nerve fiber layer using a special camera. The goal is to see if finerenone can slow down eye damage, which is a common problem in kidney disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alexandria University
Alexandria, 21532, Egypt
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.